Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription 13.05.2024 1 Am J Epidemiol 2 Ann Intern Med 1 BMJ 1 Br J Ophthalmol 3 Diabet Med 4 Diabetes Care 15 Diabetes Obes Metab 1 Diabetologia 1 Invest Ophthalmol Vis Sci 4 J Clin Endocrinol Metab 2 J Diabetes Complications 1 Obstet Gynecol 16 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. HAMILTON F, Mitchell R, Ghazal P, Timpson N, et al
   Phenotypic Associations With the HMOX1 GT(n) Repeat in European Populations.
   Am J Epidemiol. 2024;193:718-726.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. O'BRIEN C, Dinneen SF
   In type 2 diabetes, the effectiveness and side effects of GLP-1 RAs vary.
   Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0028.
   PubMed         Abstract available
   
   
3. BATES ER
   In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
   Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026.
   PubMed         Abstract available
   
   

   
   BMJ

4. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
   Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
   BMJ. 2024;385:e077097.
   PubMed         Abstract available
   
   

   
   Br J Ophthalmol

5. VINGOPOULOS F, Baldwin G, Katz R, Cui Y, et al
   Associations of quantitative contrast sensitivity with vascular metrics on widefield swept-source OCT angiography across stages of diabetic retinopathy.
   Br J Ophthalmol. 2024 May 6:bjo-2023-323900. doi: 10.1136/bjo-2023-323900.
   PubMed         Abstract available
   
   

   
   Diabet Med

6. HAUGVIK S, Hennekes M, Stice E, de Wit M, et al
   The diabetes body project: Study protocol of a multi-site trial of a virtually delivered eating disorder prevention program for young women with type 1 diabetes.
   Diabet Med. 2024 May 9:e15334. doi: 10.1111/dme.15334.
   PubMed         Abstract available
   
   
7. SCHEUER SH, Fleetwood K, Wild SH, Jackson CA, et al
   Ethnic disparities in quality of diabetes care in Scotland: A national cohort study.
   Diabet Med. 2024 May 8:e15336. doi: 10.1111/dme.15336.
   PubMed         Abstract available
   
   
8. NG SM, Evans ML, Oliver N, Rankin D, et al
   Bridging the digital divide: The UNBIASED national study to unravel the impact of ethnicity and deprivation on diabetes technology disparities in the United Kingdom.
   Diabet Med. 2024 May 8:e15346. doi: 10.1111/dme.15346.
   PubMed        
   
   

   
   Diabetes Care

9. JOHANSSON KS, Jimenez-Solem E, Petersen TS, Christensen MB, et al
   Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020.
   Diabetes Care. 2024 May 6:dc240011. doi: 10.2337/dc24-0011.
   PubMed         Abstract available
   
   
10. PANE A, Videla L, Calvet A, Viaplana J, et al
    Hypothalamic Inflammation Improves Through Bariatric Surgery, and Hypothalamic Volume Predicts Short-Term Weight Loss Response in Adults With or Without Type 2 Diabetes.
    Diabetes Care. 2024 May 7:dc232213. doi: 10.2337/dc23-2213.
    PubMed         Abstract available
    
    
11. BILAL A, Yi F, Whitaker K, Igudesman D, et al
    Impaired Awareness of Hypoglycemia in Older Adults With Type 1 Diabetes: A Post Hoc Analysis of the WISDM Study.
    Diabetes Care. 2024 May 7:dc240201. doi: 10.2337/dc24-0201.
    PubMed         Abstract available
    
    
12. BUCKELL J, Mitchell CA, Fryer K, Newbert C, et al
    Erratum. Identifying Preferred Features of Weight Loss Programs for Adults With or at Risk of Type 2 Diabetes: A Discrete Choice Experiment With 3,960 Adults in the U.K.. Diabetes Care 2024;47:739-746.
    Diabetes Care. 2024 May 10:dc24er07b. doi: 10.2337.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

13. THOMAS L, Martel E, Rist W, Uphues I, et al
    The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.
    Diabetes Obes Metab. 2024;26:2368-2378.
    PubMed         Abstract available
    
    
14. MILANOVIC S, Dedic N, Lew R, Burton D, et al
    TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes.
    Diabetes Obes Metab. 2024;26:2466-2475.
    PubMed         Abstract available
    
    
15. LIU Y, Kimita W, Shamaitijiang X, Skudder-Hill L, et al
    Intra-pancreatic fat is associated with continuous glucose monitoring metrics.
    Diabetes Obes Metab. 2024;26:2359-2367.
    PubMed         Abstract available
    
    
16. STRATMANN B, Eggers B, Mattern Y, de Carvalho TS, et al
    Maladaptive response following glucose overload in GLUT4-overexpressing H9C2 cardiomyoblasts.
    Diabetes Obes Metab. 2024;26:2379-2389.
    PubMed         Abstract available
    
    
17. LUIZ MM, Maximo RO, de Oliveira DC, Ramirez PC, et al
    Could poor glycaemic control be a predictor of walking speed decline in older adults? Evidence from the English Longitudinal Study of Ageing.
    Diabetes Obes Metab. 2024;26:2349-2358.
    PubMed         Abstract available
    
    
18. PULKKINEN MA, Varimo TJ, Hakonen ET, Hero MT, et al
    During an 18-month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range.
    Diabetes Obes Metab. 2024;26:2431-2438.
    PubMed         Abstract available
    
    
19. ABDELMALEK MF, Harrison SA, Sanyal AJ
    The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis.
    Diabetes Obes Metab. 2024;26:2001-2016.
    PubMed         Abstract available
    
    
20. HASHEMY H, Nguyen A, Khafagy R, Roshandel D, et al
    Analyses of potential causal contributors to increased waist/hip ratio-associated cardiometabolic disease: A combined and sex-stratified Mendelian randomization study.
    Diabetes Obes Metab. 2024;26:2284-2291.
    PubMed         Abstract available
    
    
21. TOSHIMITSU T, Gotou A, Sashihara T, Hojo K, et al
    Ingesting probiotic yogurt containing Lactiplantibacillus plantarum OLL2712 improves glycaemic control in adults with prediabetes in a randomized, double-blind, placebo-controlled trial.
    Diabetes Obes Metab. 2024;26:2239-2247.
    PubMed         Abstract available
    
    
22. SILVERII GA, Marinelli C, Mannucci E, Rotella F, et al
    Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials.
    Diabetes Obes Metab. 2024;26:2505-2508.
    PubMed        
    
    
23. PETERMANN-ROCHA F, Apolinar E, Nazar G, Diaz-Toro F, et al
    Associations of diabesity with all-cause and cardiovascular disease mortality: Findings from the Mexico City Prospective Study.
    Diabetes Obes Metab. 2024;26:2199-2208.
    PubMed         Abstract available
    
    
24. SHIKAMURA M, Takayama A, Takeuchi M, Kawakami K, et al
    Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A
    Diabetes Obes Metab. 2024 May 6. doi: 10.1111/dom.15632.
    PubMed         Abstract available
    
    
25. MORIOKA T, Takeuchi M, Ozeki A, Emoto M, et al
    A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).
    Diabetes Obes Metab. 2024 May 7. doi: 10.1111/dom.15644.
    PubMed         Abstract available
    
    
26. KANAOKA T, Wakui H, Yano Y, Nagasu H, et al
    Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.
    Diabetes Obes Metab. 2024 May 8. doi: 10.1111/dom.15611.
    PubMed         Abstract available
    
    
27. ALMUALLEM S, Ali AK, Vourtzoumis P, Demyttenaere S, et al
    Validation of the Individualized Metabolic Surgery score in predicting long-term remission of diabetes after duodenal switch-type procedures.
    Diabetes Obes Metab. 2024 May 9. doi: 10.1111/dom.15647.
    PubMed         Abstract available
    
    

    
    Diabetologia

28. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    PubMed        
    
    

    
    Invest Ophthalmol Vis Sci

29. 
    Erratum in: Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.
    Invest Ophthalmol Vis Sci. 2024;65:12.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

30. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
    Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
    PubMed         Abstract available
    
    
31. DENG R, Chen W, Zhang Z, Zhang J, et al
    Association between visceral obesity index and diabetes: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2024 May 6:dgae303. doi: 10.1210.
    PubMed         Abstract available
    
    
32. NICOLI CD, Long DL, Plante TB, Judd SE, et al
    N-Terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
    J Clin Endocrinol Metab. 2024 May 4:dgae301. doi: 10.1210.
    PubMed         Abstract available
    
    
33. OKOSHI C, Kyozuka H, Fukuda T, Yasuda S, et al
    Risk of gestational diabetes in women with PCOS based on body mass index: The Japan Environment and Children's Study.
    J Clin Endocrinol Metab. 2024 May 4:dgae293. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

34. HUANG JX, Copeland TP, Pitts CE, Myers SR, et al
    Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes.
    J Diabetes Complications. 2024;38:108762.
    PubMed         Abstract available
    
    
35. SHAPIRO ALB, Tjaden AH, Edelstein SL, Kahn SE, et al
    The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study.
    J Diabetes Complications. 2024;38:108764.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

36. CRUMP C, Sundquist J, Sundquist K
    Long-Term Risk of Type 2 Diabetes After Preterm Delivery or Hypertensive Disorders of Pregnancy.
    Obstet Gynecol. 2024 May 9. doi: 10.1097/AOG.0000000000005604.
    PubMed         Abstract available
    
    

    
    PLoS One

37. CHEN W, Sun X, Han J, Wu X, et al
    Joint effect of abnormal systemic immune-inflammation index (SII) levels and diabetes on cognitive function and survival rate: A population-based study from the NHANES 2011-2014.
    PLoS One. 2024;19:e0301300.
    PubMed         Abstract available
    
    
38. DERESE A, Gebreegzhiabhere Y, Medhin G, Sirgu S, et al
    Impact of depression on self-efficacy, illness perceptions and self-management among people with type 2 diabetes: A systematic review of longitudinal studies.
    PLoS One. 2024;19:e0302635.
    PubMed         Abstract available
    
    
39. WILSON D, Diji AK, Marfo R, Amoh P, et al
    Dietary adherence among persons with type 2 diabetes: A concurrent mixed methods study.
    PLoS One. 2024;19:e0302914.
    PubMed         Abstract available
    
    
40. ALSHAMMARI F, Ansari M, Khan KU, Neupane D, et al
    Health-related quality of life among people with diabetes: A cross-sectional study in Hail region, Saudi Arabia ?.
    PLoS One. 2024;19:e0299995.
    PubMed         Abstract available
    
    
41. ATRESE T, Fekadu L, Kune G, Shita A, et al
    Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional study.
    PLoS One. 2024;19:e0302167.
    PubMed         Abstract available
    
    
42. IDRIS NF, Ismail MA, Jaya MIM, Ibrahim AO, et al
    Stacking with Recursive Feature Elimination-Isolation Forest for classification of diabetes mellitus.
    PLoS One. 2024;19:e0302595.
    PubMed         Abstract available
    
    
43. OTA A, Kitamura H, Sugimoto K, Ogawa M, et al
    Comparative studies of hair shaft components between healthy and diseased donors.
    PLoS One. 2024;19:e0301092.
    PubMed         Abstract available
    
    
44. 
    Correction: Can diabetes patients seeking a second hospital get better care? Results from nested case-control study.
    PLoS One. 2024;19:e0303550.
    PubMed         Abstract available
    
    
45. SELVAVINAYAGAM TS, Viswanathan V, Ramalingam A, Kangusamy B, et al
    Prevalence of Noncommunicable Disease (NCDs) risk factors in Tamil Nadu: Tamil Nadu STEPS Survey (TN STEPS), 2020.
    PLoS One. 2024;19:e0298340.
    PubMed         Abstract available
    
    
46. SVENSSON AK, Dahlin LB, Rydberg M, Perez R, et al
    Surgery for carpal tunnel syndrome in patients with and without diabetes-Is there a difference in the frequency of surgical procedures?
    PLoS One. 2024;19:e0302219.
    PubMed         Abstract available
    
    
47. SUGLO JN, Winkley K, Sturt J
    Improving foot self-care in people with diabetes in Ghana: A development and feasibility randomised trial of a context appropriate, family-orientated diabetic footcare intervention.
    PLoS One. 2024;19:e0302385.
    PubMed         Abstract available
    
    
48. CHONA EZ, Kayange LF, Iseselo MK
    Barriers and facilitators to satisfaction with diabetes care: The perspectives of patients attending public diabetic clinics in Dar es Salaam, Tanzania.
    PLoS One. 2024;19:e0302858.
    PubMed         Abstract available
    
    
49. YINGKLANG M, Chaidee A, Dangtakot R, Jantawong C, et al
    Correction: Association of Strongyloides stercoralis infection and type 2 diabetes mellitus in northeastern Thailand: Impact on diabetic complication-related renal biochemical parameters.
    PLoS One. 2024;19:e0303774.
    PubMed         Abstract available
    
    
50. ABDEL-RAHMAN N, Manor O, Cohen A, Elran E, et al
    Adherence to diabetes quality indicators in primary care and all-cause mortality: A nationwide population-based historical cohort study.
    PLoS One. 2024;19:e0302422.
    PubMed         Abstract available
    
    
51. STOWELL M, Dobson R, Garner K, Baig M, et al
    Digital interventions for self-management of prediabetes: A scoping review.
    PLoS One. 2024;19:e0303074.
    PubMed         Abstract available
    
    
52. SHUMYE AF, Tegegne MM, Eticha BL, Bekele MM, et al
    Prevalence and associated factors of proliferative diabetic retinopathy among adult diabetic patients in Northwest Ethiopia, 2023: A cross-sectional multicenter study.
    PLoS One. 2024;19:e0303267.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.